FDA Center for Drug Evaluation and Research - What's New This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Novel Drug Approvals for 2024
Innovative drugs often mean new treatment options for patients and advances in health care for the American public. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 9, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Novel Drug Approvals for 2023
Each year, CDER approves a wide range of new drugs and biological products. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 9, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Novel Drug Approvals at FDA
Innovation drives progress. When it comes to innovation in the development of new drugs and therapeutic biological products, FDA ’s Center for Drug Evaluation and Research (CDER) supports the pharmaceutical industry at every step of the process. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 9, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA Roundup: April 9, 2024
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 9, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Buying & Using Medicine Safely
The information in this section can help you work with your health professionals to make the best medicine choices, buy safely, and use medicine so it's as safe and effective as possible. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 9, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FirstCham Co., Ltd. - 672903 - 04/03/2024
CGMP/Finished Pharmaceuticals/Adulterated/Misbranded (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 9, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Antaria Pty. Ltd. - 674495 - 03/22/2024
CGMP/Active Pharmaceutical Ingredient (API)/Adulterated (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 9, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Kilitch Healthcare India Limited - 672956 - 03/28/2024
CGMP/Finished Pharmaceutical/Adulterated (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 9, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Regulatory Education for Industry (REdI) Annual Conference 2024: Biologics Track
The Biologics Track will focus on the developmental and regulatory topics relevant to cellular and gene therapies, tissue-engineered products, blood products, vaccines, and other biological products. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 8, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Regulatory Education for Industry (REdI) Annual Conference 2024: Devices Track
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 8, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Regulatory Education for Industry (REdI) Annual Conference 2024: Drugs Track
The drugs track will address major advances and innovation across various aspects of the drug development spectrum. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 8, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Regulatory Education for Industry (REdI) Annual Conference 2024: Innovation in Medical Product Development - 05/29/2024
Regulatory Education for Industry (REdI) Annual Conference 2024: Innovation in Medical Product Development (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 8, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Quality Metrics for Drug Manufacturing
Quality Metrics Data Reporting: This program will help FDA to address common quality issues in the pharmaceutical industry, address product shortage issues, and encourage modernization of pharmaceutical manufacturing. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 5, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA Roundup: April 5, 2024
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 5, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Ivermectin and COVID-19
There continues to be interest in a drug called ivermectin for the prevention or treatment of COVID-19 in humans. The FDA has not authorized or approved ivermectin for use in preventing or treating COVID-19 in humans or animals. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 5, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news